ATE357231T1 - Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung - Google Patents
Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitungInfo
- Publication number
- ATE357231T1 ATE357231T1 AT01902073T AT01902073T ATE357231T1 AT E357231 T1 ATE357231 T1 AT E357231T1 AT 01902073 T AT01902073 T AT 01902073T AT 01902073 T AT01902073 T AT 01902073T AT E357231 T1 ATE357231 T1 AT E357231T1
- Authority
- AT
- Austria
- Prior art keywords
- taste
- masked
- linezolid
- fast
- disintegrating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17723300P | 2000-01-20 | 2000-01-20 | |
| US09/506,051 US6451345B1 (en) | 2000-01-20 | 2000-02-17 | Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357231T1 true ATE357231T1 (de) | 2007-04-15 |
Family
ID=26873062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01902073T ATE357231T1 (de) | 2000-01-20 | 2001-01-16 | Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6451345B1 (de) |
| EP (1) | EP1248616B1 (de) |
| AT (1) | ATE357231T1 (de) |
| AU (1) | AU2001227915A1 (de) |
| DE (1) | DE60127379D1 (de) |
| WO (1) | WO2001052848A2 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
| US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
| US7488496B2 (en) | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| US20050269722A1 (en) * | 2002-07-17 | 2005-12-08 | Stefano De Luigi Brushci | Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
| MXPA05000322A (es) * | 2002-07-19 | 2005-03-31 | Aventis Pharma Sa | Composicion oral de telitromicina con sabor enmascarado. |
| US20040208936A1 (en) * | 2002-07-22 | 2004-10-21 | Roland Chorin | Novel compositions |
| US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
| US20040191326A1 (en) * | 2003-03-31 | 2004-09-30 | Reo Joseph P. | Taste-masking vehicle for coated oxazolidinone particles |
| US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
| US8168228B2 (en) * | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
| US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
| US8545881B2 (en) * | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| IS7724A (is) * | 2005-03-02 | 2006-09-03 | Actavis Group | Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat |
| US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
| US20080014257A1 (en) * | 2006-07-14 | 2008-01-17 | Par Pharmaceutical, Inc. | Oral dosage forms |
| JP5228359B2 (ja) * | 2007-04-12 | 2013-07-03 | ニプロ株式会社 | 主薬粒子及びその製造方法ならびに口腔内崩壊錠 |
| FR2918296B1 (fr) | 2007-07-05 | 2009-09-18 | Oreal | Capsules de type noyau/ecorce et procede de preparation |
| TW200938186A (en) * | 2008-02-13 | 2009-09-16 | Eurand Inc | Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
| WO2010046933A2 (en) | 2008-10-22 | 2010-04-29 | Rubicon Research Private Limited | Pharmaceutical compositions of taste-masked linezolid |
| EP3632417A1 (de) * | 2009-01-30 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Dragees mit 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrolo [3,4-b] pyrazin |
| WO2011080570A2 (en) * | 2009-12-29 | 2011-07-07 | Micro Labs Limited | Extended release pharmaceutical composition comprising linezolid and process for preparing the same |
| CA2802994A1 (en) | 2010-06-17 | 2011-12-22 | The United States Of America As Represented By The Secretary, National I Nstitutes Of Health | Compositions and methods for treating inflammatory conditions |
| CA2818249C (en) * | 2010-11-24 | 2021-04-13 | Rib-X Pharmaceuticals, Inc. | Pharmaceutical compositions comprising radezolid, hydroxypropylmethyl cellulose polymer, and a physical mixture |
| US20120308662A1 (en) * | 2011-06-01 | 2012-12-06 | Nitto Denko Corporation | Particulate preparation and method for producing the same |
| JP6003890B2 (ja) | 2011-06-10 | 2016-10-05 | ニプロ株式会社 | 口腔内崩壊錠の製造方法 |
| WO2013088389A1 (en) * | 2011-12-14 | 2013-06-20 | Alembic Pharmaceuticals Limited | Linezolid premix |
| GR1008143B (el) | 2013-03-11 | 2014-03-14 | "Φαρματεν Α.Β.Ε.Ε.", | Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου |
| CN104739788B (zh) * | 2013-12-27 | 2018-02-16 | 桂林南药股份有限公司 | 一种小儿利奈唑胺组合物冻干口腔崩解片及其制备方法 |
| WO2015130760A1 (en) | 2014-02-25 | 2015-09-03 | Orbis Biosciences, Inc. | Taste masking drug formulations |
| CN105055354B (zh) * | 2015-09-08 | 2017-11-21 | 深圳万乐药业有限公司 | 一种利奈唑胺片及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800087A (en) | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US4948801A (en) | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
| US5082669A (en) | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
| IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| US5075114A (en) | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
| ATE181672T1 (de) * | 1993-04-28 | 1999-07-15 | Takeda Chemical Industries Ltd | Geschmacksmaskierte feste zubereitung und verfahren zur herstellung |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| DE69811717T2 (de) | 1997-11-18 | 2003-10-16 | Pharmacia & Upjohn Co., Kalamazoo | Verwendung von oxazolidinonderivate zur behandlung von arthritis |
| WO1999037630A1 (en) | 1998-01-23 | 1999-07-29 | Versicor, Inc. | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
-
2000
- 2000-02-17 US US09/506,051 patent/US6451345B1/en not_active Expired - Lifetime
-
2001
- 2001-01-16 AU AU2001227915A patent/AU2001227915A1/en not_active Abandoned
- 2001-01-16 AT AT01902073T patent/ATE357231T1/de not_active IP Right Cessation
- 2001-01-16 DE DE60127379T patent/DE60127379D1/de not_active Expired - Lifetime
- 2001-01-16 WO PCT/US2001/001414 patent/WO2001052848A2/en not_active Ceased
- 2001-01-16 EP EP01902073A patent/EP1248616B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6451345B1 (en) | 2002-09-17 |
| DE60127379D1 (de) | 2007-05-03 |
| EP1248616B1 (de) | 2007-03-21 |
| WO2001052848A3 (en) | 2001-12-13 |
| WO2001052848A2 (en) | 2001-07-26 |
| EP1248616A2 (de) | 2002-10-16 |
| AU2001227915A1 (en) | 2001-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE357231T1 (de) | Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung | |
| CA2092074C (en) | Rapidly disintegratable multiparticulate tablet | |
| Nagar et al. | Orally disintegrating tablets: formulation, preparation techniques and evaluation | |
| US5464632A (en) | Rapidly disintegratable multiparticular tablet | |
| EP1248594B1 (de) | Formulierung mit mehrfach gepulster wirkstofffreisetzung | |
| Ubhe et al. | A brief overview on tablet and it’s types | |
| ES2219360T3 (es) | Formulaciones liquidas farmaceuticas de sabor enmascarado. | |
| EA200200126A1 (ru) | Гидродинамически сбалансированная пероральная система доставки лекарства | |
| ATE222495T1 (de) | Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat | |
| ES2201465T3 (es) | Formulado de comprimidos de monohidrato de cefadroxil. | |
| HUP0204451A2 (hu) | Nimesulidot tartalmazó szabályozott hatóanyag-leadású készítmények | |
| IL163653A (en) | Wafer-shaped pharmaceutical preparation for administering active substances having an unpleasant or bitter taste via the oral mucosa and use of at least one carbon dioxide-forming substance for masking the unpleasant taste of said preparation | |
| CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
| EP1161956A4 (de) | Medikamentenzusammensetzung | |
| HUP0000943A2 (hu) | Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban | |
| US5702723A (en) | Multi-stage delivery system for ingestible medications or nutrients | |
| US20090202597A1 (en) | Ache-Nmda Combination Wafer | |
| HUP0105481A2 (hu) | Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk | |
| FI20000780A7 (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| EA012324B1 (ru) | Быстрораспадающаяся таблетка | |
| US20060043207A1 (en) | Apparatus, kit and related methods for administering substances | |
| US20180318228A1 (en) | Method for a slow release of drugs from orally dissolving capsules | |
| US9339475B2 (en) | Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals | |
| Parveen et al. | Fast Dissolving Tablets Using Natural Polymers: A Comprehensive Review on Formulation Strategies, Mechanisms, and Future Prospects | |
| RU2192846C2 (ru) | Гомеопатическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |